Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to evaluate the safety, tolerability and potential effectiveness of
a new investigational drug, bryostatin 1, in patients with Alzheimer's disease (AD).